insights_auto
Why is INO down २४.२४%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.१०
arrow_downward
-२४.२४%(-०.३५) 1D
नोभेम्बर ६, १०:४२:३२ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.१२
High
US$ १.१९
Low
US$ १.०७
Mkt. cap
११.३६ करोड
Avg. vol.
१.६२ करोड
Volume
१.५१ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.१२
High
US$ १.१९
Low
US$ १.०७
Mkt. cap
११.३६ करोड
Avg. vol.
१.६२ करोड
Volume
१.५१ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Benzinga
·
३ घण्टा पहिले
12 Health Care Stocks Moving In Friday's Pre-Market Session
GuruFocus
·
८ घण्टा पहिले
INOVIO Pharmaceuticals (INO) Announces $75M Public Offering, Sha
Investing.com
·
११ घण्टा पहिले
Inovio prices $75 million public offering at $1.05 per share
TradingView
·
११ घण्टा पहिले
Inovio Announces Pricing Of Approximately $75 Million Public Offering At $1.05 Per Share
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc